Abstract
BackgroundImmune checkpoint protein V-domain immunoglobulin suppressor of T cell activation (VISTA) controls antitumor immunity and is a valuable target for cancer immunotherapy. Previous mechanistic studies have indicated that VISTA impairs...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have